SEQUELLA
Sequella is a clinical-stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment paradigms for diseases of epidemic potential. The company was founded in 1997 and headquartered in Rockville, Maryland.
SEQUELLA
Industry:
Biotechnology Developer Platform Health Care
Founded:
1997-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.sequella.com
Total Employee:
11+
Status:
Active
Contact:
3017627778
Total Funding:
48.37 M USD
Technology used in webpage:
Google Analytics Google Analytics Classic OpenResty Network Solutions DNS Shockwave Flash Embed Adobe Dreamweaver Network Solutions Intermedia
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.sequella.com Semrush global rank: 4.19 M Semrush visits lastest month: 2.82 K
- Host name: vux.netsolhost.com
- IP address: 206.188.192.194
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Sequella"
Sequella - Crunchbase Company Profile & Funding
Organization. Sequella . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Sequella is a clinical-stage biopharmaceutical company, develops products for the diagnosis and …See details»
Sequella Overview
[email protected] 9610 Medical Center Drive, Suite 200 Rockville, MD 20850 Ph: 301-762-7776 Fax: 301-762-7778See details»
Management - Sequella
Prior to Sequella, Dr. Nacy served during 1997 and 1998 as Chief Scientific Officer (CSO) for Anergen, Inc. (NASDAQ: ANRG), a California company acquired by Corixa Corporation in …See details»
Board of Directors - sequella.com
He is also the Corporate Attorney for the Company and has been instrumental in its organization and development of its structure. Mr. Miller has been a Partner in the law firm Grossberg, …See details»
Sequella, Inc. - LinkedIn
Sequella is a private, clinical-stage pharmaceutical company that addresses the challenge of antibiotic-resistant bacterial diseases by discovery, development, and commercialization of …See details»
Sequella Company Profile | Management and Employees List
Sequella (USA) is a private company engaged in the development of brand new drugs for antibiotic-resistant infections treatment. The company was founded 19 years ago. It is …See details»
Sequella Company Profile - Office Locations, Competitors ... - Craft
Sequella is a clinical-stage pharma company that develops antibiotics to address drug-resistant bacterial, fungal, and parasitic infections. Its lead drug candidate is in Phase 2 clinical trials for …See details»
Sequella - Overview, News & Similar companies | ZoomInfo.com
Sequella (USA) is a private company engaged in the development of brand new drugs for antibiotic-resistant infections treatment. The company was fo unded 19 years ago. It is …See details»
Sequella, Inc. Overview | SignalHire Company Profile
Sequella, Inc. is a private company that has been in the industry for 26 years. The company currently specializes in the Biotechnology, Biotechnology areas ... Organization Website: …See details»
Sequella - Products, Competitors, Financials, Employees, …
Sequella is a clinical-stage pharmaceutical company focused on developing novel antibiotics for drug-resistant bacterial, fungal, and parasitic infections. Use the CB Insights Platform to …See details»
Sequella Company Profile 2024: Valuation, Funding
Sequella General Information Description. Developer of novel antibiotics designed to address drug-resistant bacterial, fungal and parasitic infections. The company's antibiotics portfolio addresses mycobacterium tuberculosis, Helicobacter …See details»
SEQUELLA, INC. - VentureRadar
Sequella develops novel small molecule and natural product-based therapeutics for a variety of infectious diseases. Our Drug Discovery Programs identify new scaffolds with antibacterial and …See details»
Sequella, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Sequella, Inc. with its drug pipeline, therapeutic area, technology platform, 12 clinical trials, 1 news, and 24 literature, Disease Domain:Infectious ...See details»
Sequella, Inc. Company Profile | Rockville, MD | Competitors ...
Find company research, competitor information, contact details & financial data for Sequella, Inc. of Rockville, MD. Get the latest business insights from Dun & Bradstreet.See details»
Sequella - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Sequella . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Sequella, Inc. | SBIR.gov
Sequella, Inc. Company Information. Address. 9610 MEDICAL CENTER DR STE 200. ROCKVILLE, MD 20850-6356. United States ... Tuberculosis (TB) has a massive impact on …See details»
Mission and Milestones - Sequella
Sequella presents four abstracts at Interscience Conference on Antimicrobial Activities and Chemotherapy (ICAAC) 2013. Paige MacDonald, CPA, joins Sequella Board Sequella …See details»
Sequella - EquityNet
Sequella, Inc., a clinical stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment …See details»
Sequella - Company Profile - Tracxn
Dec 11, 2024 Sequella. has raised a total funding of $9.71M over 11 rounds. Its first funding round was on Jun 15, 2008. List of recent funding rounds of Sequella. Date of funding. …See details»
Sequella, Inc. | Working Group for New TB Drugs
Sequella, Inc. First Name: Leo . Last Name: Einck. Country: United States. E-mail: [email protected]. Organization Type: Pharmaceutical/Biotech; Allow Contact: Would …See details»